A New Care Model Reduces Polypharmacy and Potentially Inappropriate Medications in Long-Term Care.

Journal of the American Medical Directors Association
Carolina Tisnado GarlandCaroline Sirois

Abstract

Assess the impact of a new pharmaceutical care model on (1) polypharmacy and (2) potentially inappropriate medication (PIM) use in long-term care facilities (LTCFs). Pragmatic quasi-experimental study with a control group. This multifaceted model enables pharmacists and nurses to increase their professional autonomy by enforcing laws designed to expand their scope of practice. It also involves a strategic reorganization of care, interdisciplinary training, and systematic medication reviews. Two LTCFs exposed to the model (409 residents) were compared to 2 control LTCFs (282 residents) in Quebec, Canada. All individuals were aged 65 years or older and residing in included LTCFs. Polypharmacy (≥10 medications) and PIM (2015 Beers criteria) were analyzed throughout 12 months between March 2017 and June 2018. Groups were compared before and after implementation using repeated measures mixed Poisson or logistic regression models, adjusting for potential confounding variables. Over 12 months, for regular medications, polypharmacy decreased from 42% to 20% (exposed group) and from 50% to 41% (control group) [difference in differences (DID): 13%, P < .001]. Mean number of PIMs also decreased from 0.79 to 0.56 (exposed group) and from 1...Continue Reading

References

Mar 17, 2010·The American Journal of Geriatric Pharmacotherapy·Lisa L DwyerElizabeth A Rechtsteiner
Jul 14, 2010·The American Journal of Geriatric Pharmacotherapy·Zachary A MarcumJoseph T Hanlon
Jan 26, 2011·Age and Ageing·Mathumalar LoganathanAzeem Majeed
Oct 1, 2013·Expert Opinion on Drug Safety·Robert L MaherEmily R Hajjar
Oct 9, 2015·Journal of the American Geriatrics Society·UNKNOWN By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel
Nov 29, 2016·Journal of the American Medical Directors Association·Kaeshaelya ThiruchelvamTherese Kairuz
Dec 10, 2016·Research in Social & Administrative Pharmacy : RSAP·Kathleen AbrahamsonKaris Pressler
Aug 3, 2017·Journal of the American Medical Directors Association·Stephanie K NothelleJodi B Segal
Aug 9, 2017·Journal of the American Pharmacists Association : JAPhA·Nattawut LeelakanokMarin L Schweizer
Oct 12, 2017·BMC Geriatrics·Nashwa MasnoonGillian E Caughey
Dec 13, 2018·Expert Opinion on Drug Safety·Jonas W WastessonKristina Johnell
Feb 26, 2019·Therapeutic Advances in Drug Safety·Denis CurtinDenis O'Mahony
Sep 1, 2019·Pharmacy : Journal of Pharmacy, Education and Practice·Caroline SiroisValérie Émond
Nov 2, 2019·Journal of the American Medical Directors Association·Benoit CossetteUNKNOWN OPUS-AP investigators
Nov 7, 2019·Pharmacy : Journal of Pharmacy, Education and Practice·Kjell H HalvorsenBeate H Garcia
Jan 29, 2020·Journal of the American Pharmacists Association : JAPhA·Cheryl A SadowskiSujin Kim

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.